European VCs may be better prepared for a downturn than their US peers Posted on 11.07.202218.07.2022 by Oliver Kahl
BioNTechs second act: can it transform the fight against cancer? Posted on 15.06.202230.06.2022 by Oliver Kahl
https://www.reuters.com/article/ac-immune-affiris/ac-immune-lures-biontech-investors-buys-%20parkinsons-vaccine-candidate-idUSL8N2P32CQ Posted on 29.07.202129.06.2022 by Oliver Kahl
